Skip to main content
Erschienen in: Journal of Medical Case Reports 1/2017

Open Access 01.12.2017 | Case report

Soy isoflavones inducing overt hypothyroidism in a patient with chronic lymphocytic thyroiditis: a case report

verfasst von: Yuya Nakamura, Isao Ohsawa, Yoshikazu Goto, Mayumi Tsuji, Tatsunori Oguchi, Naoki Sato, Yuji Kiuchi, Motonori Fukumura, Masahiro Inagaki, Hiromichi Gotoh

Erschienen in: Journal of Medical Case Reports | Ausgabe 1/2017

Abstract

Background

Many people have thyroid conditions that make them susceptible to hypothyroidism. If the foods they eat may interfere with the production of thyroid hormone, which can lead to development of serious hypothyroidism. The danger of health drinks should always be noted.

Case presentation

A 72-year-old Japanese woman was previously diagnosed with chronic lymphocytic thyroiditis caused by a goiter and had an elevated thyroid-stimulating hormone level (6.56 μIU/ml), a high anti-thyroid peroxidase antibody level (>600 IU/ml), and a high antithyroglobulin level (> 4000 IU/ml) but normal levels of free triiodothyronine (3.08 pg/ml) and thyroxine (1.18 ng/ml). She presented to our hospital with sudden-onset general malaise, edema, and hoarseness with an elevated thyroid-stimulating hormone (373.3 μIU/ml) level and very low triiodothyronine (< 0.26 pg/ml) and thyroxine (0.10 ng/ml) levels. It was determined that for 6 months she had been consuming a processed, solved health drink (“barley young leaf”) in amounts of 9 g/day, which included soybean and kale powder extract. Hypothyroidism might be affected by ingredients of health drinks. She discontinued consumption of the health drink immediately and began taking 12.5 μg of levothyroxine. The amount of levothyroxine was gradually increased every 3 days up to 100 μg. At day 61, her thyroid-stimulating hormone level had decreased (6.12 μIU/ml), her free triiodothyronine (2.69 pg/ml) and thyroxine (1.56 ng/ml) levels had increased, and her general condition was improved. Among risky foods lowering thyroid function, some experimental studies have revealed that isoflavones reduce thyroid function. Therefore, we measured the presence of isoflavones in the patient’s frozen serum with thin-layer chromatography. After she discontinued consumption of the health drink, two components quickly disappeared, and the other three components gradually decreased. On the basis of developing solvent composition and a positive ferric chloride reaction in thin-layer chromatography experiment, the five ingredients that disappeared or decreased were highly suspected to be soy isoflavones.

Conclusions

This case emphasizes that consuming health drinks that include soy isoflavone powder extracts can lead to severe hypothyroidism.

Background

Many people have thyroid conditions that make them susceptible to hypothyroidism. For example, 10% of a disease-free population was reported to have positive results for anti-thyroid peroxidase antibodies (TPOAb) or antithyroglobulin (anti-Tg) [1], indicating that many patients have potentially chronic lymphocytic thyroiditis. However, there are many exogenous foods influencing the thyroid. If the foods interfere with the production of thyroid hormone, they can cause serious hypothyroidism.
We report a case of a patient with severe hypothyroidism induced by consuming a health drink. To the best of our knowledge, there are almost no other reports of patients with severe hypothyroidism induced by isoflavone. The components of the substances suspected to be isoflavones disappeared or decreased along with the clinical impairment of our patient. To the best of our knowledge, this is the first report of the presence of isoflavone in the serum of a patient with severe hypothyroidism.

Case presentation

A 72-year-old Japanese woman had been followed because of chronic lymphocytic thyroiditis caused by a goiter. She had an elevated thyroid-stimulating hormone (TSH) level (6.56 μIU/ml), a high TPOAb level (> 600 IU/ml), and a high anti-Tg level (> 4000 IU/ml) but normal levels of free triiodothyronine (T3; 3.08 pg/ml) and thyroxine (T4; 1.18 ng/ml). Her past medical history included only hypertension. She did not have any fever or neck pain suggestive of subacute or painless thyroiditis during recent months, and she had not taken any medication that would reduce thyroid function. Her social, family, and environmental histories were also unrevealing.
The patient had been taking a processed, solved health drink (“barley young leaf”) in amounts of 9 g/day, which included soybean and kale powder extract, for 6 months. She had gradually developed general malaise, edema, and hoarseness. She presented to our hospital with sudden-onset elevated TSH (373.3 μIU/ml) level and very low T3 (< 0.26 pg/ml) and T4 (0.10 ng/ml) levels. Her levels of total cholesterol, triglyceride, lactate dehydrogenase, aspartate transaminase, creatine phosphokinase, and immunoglobulin G were increased. These laboratory findings are shown in Table 1. Her goiter was swollen with mild hardness; her blood pressure at admission was 123/77 mmHg; her body temperature was 36.0 °C; and her pulse rate was 55 beats/minute. Computed tomography (Fig. 1) and thyroid ultrasound revealed bilateral thyroid enlargement. In addition, her uptake rate of 99mTc-pertechnetate was reduced. On the basis of these findings, we diagnosed severe hypothyroidism affected by ingredients of the health drink. She discontinued consumption of the health drink immediately and began taking 12.5 μg of levothyroxine. The amount of levothyroxine was gradually increased every 3 days up to 100 μg. After oral administration of levothyroxine, her high TSH levels decreased gradually, and her low free T3 and T4 levels increased. Her swelling and hoarseness disappeared, and her general condition improved. Her free T3 and T4 levels did not decrease in the follow-up period of the subsequent 6 months. The time line of this patient’s clinical course is shown in Fig. 2. Her TSH, free T3, and T4 levels are shown in Table 2.
Table 1
Patient’s laboratory findings on admission
 
Values
Normal ranges
Blood chemistry
Values
Normal ranges
Blood cell counts
 WBC, n/μl
57×102
40–90×102
TP, g/dl
8.3
6.7–8.3
 RBC, n/μl
389×104
380–480×104
Alb, g/dl
4.0
3.9–4.9
 Hb, g/dl
11.3
12.0–15.2
BUN, mg/dl
13.2
8.0–22.0
 Hct, %
36.0
35–48
Cr, mg/dl
1.0
0.4–0.7
 Plt, n/μl
13.1×104
14–34×104
UA, mg/dl
4.9
3.0–5.5
   
Na+, mEq/L
141
135–147
Serological tests
  
K+, mEq/L
3.5
3.5–5.0
 Fe, μg/dl
58
43–172
Cl, mEq/L
102
98–108
 UIBC, μg/dl
213
137–325
Ca2+, mg/dl
9.2
8.8–10.2
 TIBC, μg/dl
271
251–398
Pi, mg/dl
3.2
2.5–4.5
 Ferritin, ng/ml
72.8
5–157
AST, U/L
41
13–33
 IgG, mg/dl
2231
1156
ALT, U/L
28
6–27
 IgA, mg/dl
397
103
γ-GTP, U/L
31
10–47
 IgM, mg/dl
128
125
ALP, U/L
208
115–359
 NT-proBNP, pg/ml
49
< 125
LDH, U/L
330
119–229
   
T-Bil, mg/dl
0.6
0.2–1.2
Urinalysis
  
CPK, U/L
567
45–163
 Protein
T-chol, mg/dl
310
130–220
 Occult blood test
TG, mg/dl
233
30–150
   
HDL-chol, mg/dl
54
41.5–67.3
Fecal occult blood test
LDL-chol, mg/dl
187
70–139
   
Glu, mg/dl
85
70–110
   
CRP, mg/dl
0.15
< 0.30
Abbreviations: Alb Albumin, ALP Alkaline phosphatase, ALT Alanine transaminase, AST Aspartate transaminase, BUN Blood urea nitrogen, Ca 2+ Calcium, Cl Chloride, CPK Creatine phosphokinase, Cr Creatinine, CRP C-reactive protein, Fe Iron, γ-GTP γ-Glutamyltransferase, Glu Glucose, Hb Hemoglobin, Hct Hematocrit, HDL-chol High-density lipoprotein cholesterol, IgA Immunoglobulin A, IgG Immunoglobulin G, IgM Immunoglobulin M, K + Potassium, LDH Lactate dehydrogenase, LDL-chol Low-density lipoprotein cholesterol, Na + Sodium, NT-proBNP N-terminal pro-brain natriuretic peptide, Pi Inorganic phosphate, Plt Blood platelets, RBC Red blood cells, T-Bil Total bilirubin, T-chol Total cholesterol, T-chol Total cholesterol, TG Triglyceride, TIBC Total iron-binding capacity, TP Total protein, TSAT Transferrin saturation, UA Uric acid, UIBC Unsaturated iron-binding capacity, WBC White blood cell
Table 2
Patient’s clinical course based on laboratory findings after discharge
 
Before treatment
Day 11
Day 33
Day 61
Day 102
Normal range
TSH, μIU/ml
373.7
341.3
40.66
6.12
11.68
0.50–5.00
fT3, pg/ml
< 0.26
0.55
2.47
2.69
2.58
2.30–4.00
fT4, ng ml
0.1
0.28
1.41
1.56
1.45
0.90–1.70
Abbreviations: fT3 Free triiodothyronine, fT4 Thyroxine, TSH Thyroid-stimulating hormone
There are many risky foods lowering thyroid function, such as soybean and cruciferous vegetables, especially in a patient with chronic lymphocytic thyroiditis. Among these foods, some experimental studies have shown that isoflavone reduces thyroid function [2, 3]. It was suspected that isoflavones might be the reason for our patient’s hypothyroidism. Therefore, we measured the presence of isoflavone in the patient’s frozen serum at 5 points from before admission to day 102 for further investigation. A blood sample was pretreated as described previously [4]. The sample was analyzed with thin-layer chromatography on precoated silica gel 60 F254 or RP-18 WF254 plates (Merck Millipore Corporation, Darmstadt, Germany), with detection achieved by spraying with iron(III) chloride solution. After she discontinued consuming the health drink, two components quickly disappeared, and the other three components gradually decreased (Fig. 3). On the basis of developing solvent composition and a positive ferric chloride reaction in thin-layer chromatography experiment, the five ingredients that disappeared or decreased were highly suspected to be soy isoflavones.

Discussion

Isoflavone, one of the isoflavonoids, is associated with breast cancer, prostate cancer, cerebral infarction, and myocardial infarction [57]. Moreover, some researchers have reported that soy isoflavone might reduce thyroid function by suppressing thyroid peroxidase [2, 3]. In our patient, the components of the substances suspected to be isoflavones had disappeared or decreased along with her clinical impairment. To the best of our knowledge, this is the first case report in which the presence of isoflavone has been examined in the serum of a patient with severe hypothyroidism. This point is unique; to the best of our knowledge, there have been almost no other reports in which the presence of isoflavone has been examined in patient serum. The other following two mechanisms of hypothyroidism by soybean are considered: (1) An alcohol-soluble component in soybean inhibits iodide uptake [8], and (2) phytic acid salt in soybean chelates the essential minerals, especially zinc, for thyroid hormone production [9, 10]. Our patient presented with severe hypothyroidism after 6 months of regular consumption of a health drink. Because the thyroid contains several months’ storage of thyroid hormone [11], overt hypothyroidism might present late. It is necessary to investigate further the detailed mechanisms of hypothyroidism caused by soy isoflavones.

Conclusions

This case emphasizes that consuming health drinks that include soy isoflavone powder extract can lead to severe hypothyroidism.

Acknowledgements

Not applicable.

Funding

None.

Availability of data and materials

All data generated or analyzed for this report are included in this published article.
Not applicable.
Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://​creativecommons.​org/​licenses/​by/​4.​0/​), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated.

Unsere Produktempfehlungen

e.Med Interdisziplinär

Kombi-Abonnement

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

e.Med Allgemeinmedizin

Kombi-Abonnement

Mit e.Med Allgemeinmedizin erhalten Sie Zugang zu allen CME-Fortbildungen und Premium-Inhalten der allgemeinmedizinischen Zeitschriften, inklusive einer gedruckten Allgemeinmedizin-Zeitschrift Ihrer Wahl.

Literatur
1.
Zurück zum Zitat Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, Spencer CA, et al. Serum TSH, T4, and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab. 2002;87:489–99.CrossRefPubMed Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, Spencer CA, et al. Serum TSH, T4, and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab. 2002;87:489–99.CrossRefPubMed
2.
Zurück zum Zitat Chang HC, Doerge DR. Dietary genistein inactivates rat thyroid peroxidase in vivo without an apparent hypothyroid effect. Toxicol Appl Pharmacol. 2000;168:244–52.CrossRefPubMed Chang HC, Doerge DR. Dietary genistein inactivates rat thyroid peroxidase in vivo without an apparent hypothyroid effect. Toxicol Appl Pharmacol. 2000;168:244–52.CrossRefPubMed
3.
Zurück zum Zitat Munro IC, Harwood M, Hlywka JJ, Stephen AM, Doull J, Flamm WG, et al. Soy isoflavones: a safety review. Nutr Rev. 2003;61:1–33.CrossRefPubMed Munro IC, Harwood M, Hlywka JJ, Stephen AM, Doull J, Flamm WG, et al. Soy isoflavones: a safety review. Nutr Rev. 2003;61:1–33.CrossRefPubMed
4.
Zurück zum Zitat Kaneko H, Yamato Y, Teramura Y, Fujiwara T, Suzuki A, Kawamura A, et al. Metabolites of micafungin in rats and dogs. Jpn J Chemother. 2002;50:88–93. Kaneko H, Yamato Y, Teramura Y, Fujiwara T, Suzuki A, Kawamura A, et al. Metabolites of micafungin in rats and dogs. Jpn J Chemother. 2002;50:88–93.
5.
Zurück zum Zitat Yamamoto S, Sobue T, Kobayashi M, Sasaki S, Tsugane S. Japan Public Health Center-Based Prospective Study on Cancer Cardiovascular Diseases Group. Soy, isoflavones, and breast cancer risk in Japan. J Natl Cancer Inst. 2003;95:906–13.CrossRefPubMed Yamamoto S, Sobue T, Kobayashi M, Sasaki S, Tsugane S. Japan Public Health Center-Based Prospective Study on Cancer Cardiovascular Diseases Group. Soy, isoflavones, and breast cancer risk in Japan. J Natl Cancer Inst. 2003;95:906–13.CrossRefPubMed
6.
Zurück zum Zitat Kokubo Y, Iso H, Ishihara J, Okada K, Inoue M, Tsugane S, JPHC Study Group. Association of dietary intake of soy, beans, and isoflavones with risk of cerebral and myocardial infarctions in Japanese populations: the Japan Public Health Center-based (JPHC) study cohort I. Circulation. 2007;116:2553–62.CrossRefPubMed Kokubo Y, Iso H, Ishihara J, Okada K, Inoue M, Tsugane S, JPHC Study Group. Association of dietary intake of soy, beans, and isoflavones with risk of cerebral and myocardial infarctions in Japanese populations: the Japan Public Health Center-based (JPHC) study cohort I. Circulation. 2007;116:2553–62.CrossRefPubMed
7.
Zurück zum Zitat Kurahashi N, Iwasaki M, Sasazuki S, Otani T, Inoue M, Tsugane S, Japan Public Health Center-Based Prospective Study Group. Soy product and isoflavone consumption in relation to prostate cancer in Japanese men. Cancer Epidemiol Biomarkers Prev. 2007;16:538–45.CrossRefPubMed Kurahashi N, Iwasaki M, Sasazuki S, Otani T, Inoue M, Tsugane S, Japan Public Health Center-Based Prospective Study Group. Soy product and isoflavone consumption in relation to prostate cancer in Japanese men. Cancer Epidemiol Biomarkers Prev. 2007;16:538–45.CrossRefPubMed
8.
Zurück zum Zitat Tran L, Hammuda M, Wood C, Xiao CW. Soy extracts suppressed iodine uptake and stimulated the production of autoimmunogen in rat thyrocytes. Exp Biol Med (Maywood). 2013;238:623–30.CrossRef Tran L, Hammuda M, Wood C, Xiao CW. Soy extracts suppressed iodine uptake and stimulated the production of autoimmunogen in rat thyrocytes. Exp Biol Med (Maywood). 2013;238:623–30.CrossRef
9.
Zurück zum Zitat Zhou JR, Erdman Jr JW. Phytic acid in health and disease. Crit Rev Food Sci Nutr. 1995;35:495–508.CrossRefPubMed Zhou JR, Erdman Jr JW. Phytic acid in health and disease. Crit Rev Food Sci Nutr. 1995;35:495–508.CrossRefPubMed
10.
Zurück zum Zitat Szkudelski T. Phytic acid-induced metabolic changes in the rat. J Anim Physiol Anim Nutr (Berl). 2005;89:397–402.CrossRef Szkudelski T. Phytic acid-induced metabolic changes in the rat. J Anim Physiol Anim Nutr (Berl). 2005;89:397–402.CrossRef
11.
Zurück zum Zitat Ingbar SH, Woeber KA. The thyroid gland. In: Williams RH, editor. Textbook of endocrinology. 6th ed. New York: Saunders; 1981. p. 117–247. Ingbar SH, Woeber KA. The thyroid gland. In: Williams RH, editor. Textbook of endocrinology. 6th ed. New York: Saunders; 1981. p. 117–247.
Metadaten
Titel
Soy isoflavones inducing overt hypothyroidism in a patient with chronic lymphocytic thyroiditis: a case report
verfasst von
Yuya Nakamura
Isao Ohsawa
Yoshikazu Goto
Mayumi Tsuji
Tatsunori Oguchi
Naoki Sato
Yuji Kiuchi
Motonori Fukumura
Masahiro Inagaki
Hiromichi Gotoh
Publikationsdatum
01.12.2017
Verlag
BioMed Central
Erschienen in
Journal of Medical Case Reports / Ausgabe 1/2017
Elektronische ISSN: 1752-1947
DOI
https://doi.org/10.1186/s13256-017-1418-9

Weitere Artikel der Ausgabe 1/2017

Journal of Medical Case Reports 1/2017 Zur Ausgabe